Frontier Biotechnologies (SHSE:688221) Total Assets : ¥2,005.6 Mil (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Frontier Biotechnologies Total Assets?

Frontier Biotechnologies's Total Assets for the quarter that ended in Sep. 2024 was ¥2,005.6 Mil.

During the past 12 months, Frontier Biotechnologies's average Total Assets Growth Rate was 13.30% per year. During the past 3 years, the average Total Assets Growth Rate was 17.10% per year. During the past 5 years, the average Total Assets Growth Rate was 28.70% per year.

During the past 8 years, Frontier Biotechnologies's highest 3-Year average Total Assets Growth Rate was 43.90%. The lowest was 10.90%. And the median was 17.50%.

Total Assets is connected with ROA %. Frontier Biotechnologies's annualized ROA % for the quarter that ended in Sep. 2024 was -6.50%. Total Assets is also linked to Revenue through Asset Turnover. Frontier Biotechnologies's Asset Turnover for the quarter that ended in Sep. 2024 was 0.02.

Frontier Biotechnologies Total Assets Historical Data

The historical data trend for Frontier Biotechnologies's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Frontier Biotechnologies Total Assets Chart

Frontier Biotechnologies Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

939.53

2,525.31

2,532.63

2,410.86

2,140.13

Frontier Biotechnologies Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Assets	Get a 7-Day Free Trial															2,201.48	2,140.13	2,083.55	2,057.17	2,005.63

Frontier Biotechnologies Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Frontier Biotechnologies's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	1342.682	+	797.444
	=	2,140.1

Frontier Biotechnologies's Total Assets for the quarter that ended in Sep. 2024 is calculated as

Total Assets	=	Total Equity (Q: Sep. 2024 )	+	Total Liabilities (Q: Sep. 2024 )
	=	1149.214	+	856.414
	=	2,005.6

Frontier Biotechnologies (SHSE:688221) Total Assets Explanation

Total Assets is connected with ROA %.

Frontier Biotechnologies's annualized ROA % for the quarter that ended in Sep. 2024 is

ROA %	=	Net Income (Q: Sep. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
	=	-131.996	/	( (2057.173	+	2005.628)	/ 2 )
	=	-131.996	/	2031.4005
	=	-6.50 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Frontier Biotechnologies's Asset Turnover for the quarter that ended in Sep. 2024 is

	Asset Turnover
=	Revenue (Q: Sep. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
=	40.588	/	( (2057.173	+	2005.628)	/ 2 )
=	40.588	/	2031.4005
=	0.02

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Frontier Biotechnologies Total Assets Related Terms

Thank you for viewing the detailed overview of Frontier Biotechnologies's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Frontier Biotechnologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Frontier Biotechnologies Inc (SHSE:688221) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 5 Gande Road, 7th Floor, Science Park, Jiangning District, Jiangsu Province, Nanjing, CHN, 211122

Website

http://www.frontierbiotech.com

Frontier Biotechnologies Inc is an innovative biomedical company. It is engaged in the production and sales of innovative drugs for major unmet clinical needs. The company focuses on the research and development of new drugs in the field of long-acting peptides and differentiated product development strategies for unmet clinical and patient needs.

Frontier Biotechnologies Headlines

No Headlines